Recent News
March 31, 2026: Credicorp held its Annual General Meeting virtually, with documentation published in advance. Late February 2026: the company announced director nominees for the 2026 AGM. February 13, 2026: the company set a shareholder record date for certain corporate actions. Mid-March 2026: a Solactive index adjustment listed Credicorp effective March 16, 2026. The company published its 2026 schedule for quarterly results and conference calls in December 2025 (schedule reiterated into 2026).
Technical Analysis
ADX at 10.89 indicates no established trend; this lack of directional strength reduces conviction that short-term momentum will extend into a strong directional move and tempers the immediate impact of price-based signals on valuation.
Directional indicators diverge: DI+ shows a dip-and-reversal, which signals bullish pressure, while DI- increases, signaling rising downside pressure; this split suggests a tug-of-war between buyers and sellers that could leave price action range-bound until one side decisively wins.
MACD sits at -0.16 with a recent dip-and-reversal and now trades above its signal line (-1.29); the MACD crossing above its signal line constitutes a bullish momentum signal even though the MACD value remains slightly negative, implying momentum improvement rather than dominant bullish strength.
MRO at 2.85 remains positive, indicating price currently sits above the model target and therefore carries mild downward pressure toward mean reversion; the recent dip-and-reversal in MRO reduces the immediacy of that pressure but does not remove it.
RSI at 54.42 with a dip-and-reversal places momentum in neutral-to-mildly bullish territory; RSI neither confirms overbought conditions nor signals a clear breakout, supporting a view of controlled upside rather than runaway strength.
Price sits above the 200-day average ($280.62) and above the 20-day average ($331.43) while trading just below the 50-day average ($342.22); the 12- and 26-day EMAs (≈$334.48 and $334.46) lie beneath the close ($337.44) and show a dip-and-reversal, reinforcing short-term upward bias but with resistance near the 50-day average and the super trend upper band at $346.17.
Fundamental Analysis
Earnings: EPS came in at $5.93 versus an estimate of $6.45, a miss of $0.52 and an EPS surprise of -8.06%. Reported earnings growth stands at -8.35% overall; quarter-over-quarter earnings growth shows -9.92% and year-over-year earnings growth reads -68.49%, indicating material recent pressure on profitability that factors into valuation.
Revenue: reported revenue growth stands near 0.59% on the headline metric, with revenue year-over-year at -38.49%. Quarter-over-quarter revenue change shows 0.0%, signaling flat short-term top-line performance while annual comparisons reveal significant contraction.
Valuation multiples: trailing PE equals 52.10, which sits below the industry peer mean of 61.57 and below the industry peer median of 61.87 yet within the industry peer range (low 37.24–high 87.92). Forward PE stands at 33.21, below the industry peer mean for forward PE (≈45.38), implying forward earnings expectations reduce multiple pressure versus the trailing metric. PEG sits at -6.24 versus the industry peer mean of -3.60 (industry peer range low -8.69 to high 16.01), reflecting negative near-term earnings growth dynamics embedded in the ratio.
Cash and capital: invested capital shows $-60,612,382,000 (negative on the ledger), cash-flow-to-earnings conversion equals 0%, and cost of debt sits at 3.95%, indicating funding costs remain modest even as cash conversion shows no cushion to profits.
Forward outlook: forward EPS equals $8.08 and forward PE equals 33.21, implying analysts (or consensus inputs) expect earnings improvement; WMDST currently values the stock as fair-valued, reflecting the balance between elevated trailing multiples, depressed recent growth metrics, and improved forward-earnings expectations.
MOST-RECENT QUARTERLY REPORT
| REPORT PERIOD ENDING: | 2025-12-31 |
| REPORT DATE: | 2026-02-11 |
| NEXT REPORT DATE: | 2026-05-13 |
| CASH FLOW | Begin Period Cash Flow | — |
| Operating Cash Flow | — | |
| Capital Expenditures | — | |
| Change In Working Capital | — | |
| Dividends Paid | — | |
| Cash Flow Delta | — | |
| End Period Cash Flow | — | |
| INCOME STATEMENT | REVENUE | |
| Total Revenue | — | |
| Forward Revenue | — | |
| COSTS | ||
| Cost Of Revenue | — | |
| Depreciation | — | |
| Depreciation and Amortization | — | |
| Research and Development | — | |
| Total Operating Expenses | — | |
| PROFITABILITY | ||
| Gross Profit | — | |
| EBITDA | — | |
| EBIT | — | |
| Operating Income | — | |
| Interest Income | — | |
| Interest Expense | — | |
| Net Interest Income | — | |
| Income Before Tax | — | |
| Tax Provision | — | |
| Tax Rate | — | |
| Net Income | — | |
| Net Income From Continuing Operations | — | |
| EARNINGS | ||
| EPS Estimate | $ 6.45 | |
| EPS Actual | $ 5.93 | |
| EPS Difference | $ -0.52 | |
| EPS Surprise | -8.062 % | |
| Forward EPS | $ 8.08 | |
| BALANCE SHEET | ASSETS | |
| Total Assets | — | |
| Intangible Assets | — | |
| Net Tangible Assets | — | |
| Total Current Assets | — | |
| Cash and Short-Term Investments | — | |
| Cash | — | |
| Net Receivables | — | |
| Inventory | — | |
| Long-Term Investments | — | |
| LIABILITIES | ||
| Accounts Payable | — | |
| Short-Term Debt | — | |
| Total Current Liabilities | — | |
| Net Debt | — | |
| Total Debt | — | |
| Total Liabilities | — | |
| EQUITY | ||
| Total Equity | — | |
| Retained Earnings | — | |
| VALUATION & PER-SHARE METRICS | EQUITY & PER-SHARE METRICS | |
| Book Value Per-Share | — | |
| Shares Outstanding | — | |
| Revenue Per-Share | — | |
| VALUATION | Market Capitalization | — |
| Enterprise Value | — | |
| Enterprise Multiple | — | |
| Enterprise Multiple QoQ | — | |
| Enterprise Multiple YoY | — | |
| Enterprise Multiple IPRWA | — | |
| EV/R | — | |
| CAPITAL STRUCTURE | ||
| Asset To Equity | — | |
| Asset To Liability | — | |
| Debt To Capital | — | |
| Debt To Assets | — | |
| Debt To Assets QoQ | — | |
| Debt To Assets YoY | — | |
| Debt To Assets IPRWA | — | |
| Debt To Equity | — | |
| Debt To Equity QoQ | — | |
| Debt To Equity YoY | — | |
| Debt To Equity IPRWA | — | |
| PRICE-BASED VALUATION | ||
| Price To Book (P/B) | — | |
| Price To Book QoQ | — | |
| Price To Book YoY | — | |
| Price To Book IPRWA | — | |
| Price To Earnings (P/E) | 52.097 | |
| Price To Earnings QoQ | 32.241 % | |
| Price To Earnings YoY | 297.183 % | |
| Price To Earnings IPRWA | high: 87.915 median: 61.871 mean: 61.572 BAP: 52.097 low: 37.244 |
|
| PE/G Ratio | -6.242 | |
| Price To Sales (P/S) | — | |
| Price To Sales QoQ | — | |
| Price To Sales YoY | — | |
| Price To Sales IPRWA | — | |
| FORWARD MULTIPLES | ||
| Forward P/E | 33.214 | |
| Forward PE/G | -3.98 | |
| Forward P/S | — | |
| EFFICIENCY | OPERATIONAL | |
| Operating Leverage | — | |
| ASSET & SALES | ||
| Asset Turnover Ratio | — | |
| Asset Turnover Ratio QoQ | — | |
| Asset Turnover Ratio YoY | — | |
| Asset Turnover Ratio IPRWA | — | |
| Receivables Turnover | — | |
| Receivables Turnover Ratio QoQ | — | |
| Receivables Turnover Ratio YoY | — | |
| Receivables Turnover Ratio IPRWA | — | |
| Inventory Turnover | — | |
| Inventory Turnover Ratio QoQ | — | |
| Inventory Turnover Ratio YoY | — | |
| Inventory Turnover Ratio IPRWA | — | |
| Days Sales Outstanding (DSO) | — | |
| CASH CYCLE | ||
| Cash Conversion Cycle Days (CCC) | — | |
| Cash Conversion Cycle Days QoQ | — | |
| Cash Conversion Cycle Days YoY | — | |
| Cash Conversion Cycle Days IPRWA | high: 83.413 mean: 13.496 low: 10.154 median: 10.154 BAP: 0 |
|
| CAPITAL DEPLOYMENT | ||
| Cash Conversion Ratio | — | |
| CapEx To Revenue | — | |
| CapEx To Depreciation | — | |
| CAPITAL, LIQUIDITY & COVERAGE | CAPITAL STRUCTURE | |
| Total Capital | — | |
| Net Invested Capital | — | |
| Invested Capital | $ -60.61 B | |
| Net Tangible Assets | — | |
| Net Working Capital | — | |
| LIQUIDITY | ||
| Cash Ratio | — | |
| Current Ratio | — | |
| Current Ratio QoQ | — | |
| Current Ratio YoY | — | |
| Current Ratio IPRWA | — | |
| Quick Ratio | — | |
| Quick Ratio QoQ | — | |
| Quick Ratio YoY | — | |
| Quick Ratio IPRWA | — | |
| COVERAGE & LEVERAGE | ||
| Debt To EBITDA | — | |
| Cost Of Debt | 3.948 % | |
| Interest Coverage Ratio | — | |
| Interest Coverage Ratio QoQ | — | |
| Interest Coverage Ratio YoY | — | |
| Interest Coverage Ratio IPRWA | — | |
| Operating Cash Flow Ratio | — | |
| TIMING / LIQUIDITY | ||
| Days Payables Outstanding (DPO) | — | |
| DIVIDENDS | ||
| Dividend Coverage Ratio | — | |
| Dividend Payout Ratio | — | |
| Dividend Rate | — | |
| Dividend Yield | — | |
| PERFORMANCE | GROWTH | |
| Asset Growth Rate | — | |
| Revenue Growth | 0.585 % | |
| Revenue Growth QoQ | 0.0 % | |
| Revenue Growth YoY | -38.486 % | |
| Revenue Growth IPRWA | high: 6.191 % median: 3.449 % mean: 2.827 % BAP: 0.585 % low: -1.639 % |
|
| Earnings Growth | -8.346 % | |
| Earnings Growth QoQ | -991.667 % | |
| Earnings Growth YoY | -68.489 % | |
| Earnings Growth IPRWA | high: 12.184 % BAP: -8.346 % median: -8.679 % mean: -16.218 % low: -45.133 % |
|
| MARGINS | ||
| Gross Margin | — | |
| Gross Margin QoQ | — | |
| Gross Margin YoY | — | |
| Gross Margin IPRWA | — | |
| EBIT Margin | — | |
| EBIT Margin QoQ | — | |
| EBIT Margin YoY | — | |
| EBIT Margin IPRWA | — | |
| Return On Sales (ROS) | — | |
| Return On Sales QoQ | — | |
| Return On Sales YoY | — | |
| Return On Sales IPRWA | — | |
| CASH FLOW | ||
| Free Cash Flow (FCF) | — | |
| Free Cash Flow Yield | — | |
| Free Cash Flow Yield QoQ | — | |
| Free Cash Flow Yield YoY | — | |
| Free Cash Flow Yield IPRWA | — | |
| Free Cash Growth | — | |
| Free Cash Growth QoQ | — | |
| Free Cash Growth YoY | — | |
| Free Cash Growth IPRWA | — | |
| Free Cash To Net Income | — | |
| Cash Flow Margin | — | |
| Cash Flow To Earnings | 0.0 | |
| VALUE & RETURNS | ||
| Economic Value Added | — | |
| Return On Assets (ROA) | — | |
| Return On Assets QoQ | — | |
| Return On Assets YoY | — | |
| Return On Assets IPRWA | — | |
| Return On Capital Employed (ROCE) | — | |
| Return On Equity (ROE) | — | |
| Return On Equity QoQ | — | |
| Return On Equity YoY | — | |
| Return On Equity IPRWA | — | |
| DuPont ROE | — | |
| Return On Invested Capital (ROIC) | — | |
| Return On Invested Capital QoQ | — | |
| Return On Invested Capital YoY | — | |
| Return On Invested Capital IPRWA | — | |